Cite Filings / PHIO / 0001683168-26-006474

Feed Companies Filings Check

Sign in

DEFA14A

Proxy Materials

Phio Pharmaceuticals Corp. Filed 2026-08-14 Acc 0001683168-26-006474

Documents 1

DEFA14A Proxy Materials , phio_defa14a.htm

Around this filing

2026-08-20 4 Director bought 15,000 shares at $1.14 ($17,100)
2026-08-19 4 Chairman, Pres. & CEO bought 10,000 shares at $1.06 ($10,600)
2026-08-14 ARS Annual Report to Security Holders
2026-08-14 DEFA14A Proxy Materials
2026-08-14 DEF 14A Proxy Statement
2025-08-28 DEFA14A Proxy Materials

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading phio_defa14a.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…